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Abstract           
Objective: To explore whether a pre-consultation web-based intervention enables patients 
with diabetes to articulate their agenda in a consultation in the hospital outpatient clinic with 
their diabetologist.  
Methods and Design: A qualitative study embedded in a pragmatic pilot randomised 
controlled trial. 
Setting: Two city outpatient departments in England. 
Participants: 25 patients attending a follow-up consultation and 6 diabetologists. 
Intervention: The PACE-D, a web-based tool adapted for patients with diabetes to use 
before their consultation to generate an agenda of topics to discuss with their diabetologist. 
Data collection: 25 participants had their consultation with their diabetologist audio-
recorded: 12 in the control arm and 13 in the intervention arm; 12 of the latter also had their 
PACE-D intervention session and a consultation recorded. Semi-structured interviews with 6 
diabetologists, and 12 patients (6 in the intervention group and 6 in the control group).  
Analysis: Thematic discourse analysis undertaken with patient representatives trained in 
qualitative data analysis techniques.  
Results: We identified 4 consultation types: diabetologist facilitated; patient identified; 
consultant facilitated and patient initiated; and patient ignored. We also identified 3 critical 
aspects that explained the production and utilisation of the agenda form: existing 
consultative style; orientation to the use of the intervention; and impact on the consultation. 
Where patients and diabetologists have a shared preference for a consultant-led or patient-
led consultation the intervention augments effective communication and shared decision 
making. However, where preferences diverge (e.g. there is a mismatch in patient and 
diabetologists preferences and orientations) the intervention does not improve the potential 
for shared decision making.  
Conclusion: A simple web-based intervention facilitates the articulation of patients’ 
unvoiced agenda for a consultation with their diabetologist, but only when pre-existing 
consultation styles and orientations already favour shared-decision making. More needs to 
be done to translate patient empowerment in the consultation setting into genuine self-
efficacy. 
 
Trial registration number: ISRCTN75070242 
 
 
INTRODUCTION        
By 2045 693 million people (age 18–99 years) worldwide will have diabetes, with global 
healthcare expenditure for diabetes expected to increase by 7% from 2017 to $ 958 billion.1 
Diabetic complications are associated with substantial long-term healthcare costs, now rising 
steadily over time.2 Diabetes is largely monitored and managed by patients themselves.3 
Self-management involves complex self-care tasks, which may place a burden on those with 
diabetes, which can inhibit effective self-care.4 Advice from professionals is vital to self-
management, improving patients’ ability to cope with their illness.5 Effective consultations 
are associated with empowerment, positive behaviour change and improved diabetes 
outcomes.6-8 However, there is a lack of consensus among clinicians about the format of 
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diabetes reviews9 and patients’ concerns are often overlooked.10,11 Thus, methods to 
improve the quality of consultations in terms of the ability of the patient to discuss their 
concerns, understand information, and remember and follow advice, are consistently sought.  
Methods used to improve consultations include question checklists and patient coaching 
delivered immediately before consultations. Information-seeking behaviour and patient 
satisfaction are most improved by combining coaching with written material.12 A systematic 
review of computer-based self-management interventions for adults with Type 2 diabetes 
identified 16 randomised controlled trials, but was unable to discern the active ingredients or 
optimal ‘dose’ of the interventions.13 Previously, Greenfield et al. used a medical record 
review, a treatment algorithm and a behaviour change strategy, to improve both patient 
participation in the consultation and glycaemic control.14 Subsequently, Cegala et al. have 
suggested that communication skills training for patients can enhance their participation in 
the medical consultation.15 They have proposed the Presenting Asking Checking Expressing 
(PACE) system for patients to develop effective communication; this involves patients 
presenting detailed information about how they are feeling, asking questions if desired 
information is not provided, checking understanding of information that is given to them and 
expressing any concerns about the recommended treatment. We modified the PACE system 
specifically for diabetes to produce a web-based tool (PACE-diabetes or PACE-D), designed 
to be completed by a patient immediately before a clinic appointment with a diabetologist to 
identify the issues that they wish to discuss with them (ie, their ‘agenda’ – Figure 1).16,17 
(Supplementary file) 
[Insert figure 1 here] 
The aim of this paper is to explore whether a pre-consultation web-based intervention 
enables patients to articulate their agenda in a consultation with their diabetologist. 
METHODS 
Design 
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A qualitative study embedded in a pragmatic pilot randomised controlled trial.16 
 
Participants and Study Setting 
For the trial, we aimed to recruit 120 patients attending diabetes clinics at two outpatient 
departments in England. Eligible patients were adults with Type 1 or Type 2 diabetes who 
were due to attend outpatient appointments with their diabetologist. Participants were aged 
18 or over with basic spoken or written English, necessary to complete the outcome 
measures. Pregnant women with diabetes and diabetes patients receiving insulin pump 
therapy were excluded as they attended separate designated clinics for those conditions.  
 
Recruitment  
Potential participants were identified from clinic lists of participating consultant diabetologists 
by a research nurse at each location. Those who expressed an interest were sent a Patient 
Information Sheet, and telephoned a week later by a research nurse who established their 
willingness to participate, and sent them a Consent Form and baseline questionnaires. On 
receipt of these documents, participants were randomised to either the intervention or usual 
care. Because patients were added to the clinic list later than anticipated, with ethical 
approval this process was condensed to facilitate recruitment.17 
 
Intervention 
In a 20 minute session immediately preceding the clinic appointment, a trained HCA assisted 
the patient to complete the web-based form (Figure 1).  
The patients in the intervention arm proceeded to the clinical consultation with the printout of 
their intervention form which they handed to the diabetologist, and which then acted as an 
agenda for their consultation. Due to the nature of the intervention and the production of an 
agenda, it was impossible to blind health professionals or patients to trial allocation.  
 
Control 
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This comprised usual clinical care provided by the same diabetologists in outpatient clinics. 
 
Data Collection 
We planned to audio-record ten intervention sessions, to explore how patients utilised the 
web-based intervention and the amount of assistance that they required from the HCA. We 
also planned to audio-record 30 clinical consultations across both trial arms and study sites, 
to understand the mechanisms that underlie the impact of the production of an agenda on 
the clinical consultation, and its subsequent utilisation in practice, when compared with usual 
care.18,19 As patients, rather than diabetologists were randomised, we sought to explore the 
impact on diabetologists’ conduct, by comparing ‘naturally occurring’ data for consultations 
with patients in the control arm (to establish the natural ecology of conversations) ,and 
research generated data (from use of the agenda form in the intervention arm) for each 
diabetologist.20,21   
 We also aimed to conduct semi-structured interviews with a purposive sample of 5 clinical 
staff and 10 patients in each trial arm to explore wider organisational factors. All data were 
transcribed and anonymised, and managed using Nvivo software. 
 
Analysis 
Data analysis began with a preliminary charting exercise (JF, CA), firstly of consultations 
from the control arm and subsequently for those in the intervention arm, which allowed us to 
typify usual care and subsequently to identify any relationships between the process of 
agenda identification and agenda use.22 From the charting exercise, we identified a 
preliminary typology of consultations (Patient ignored, Consultant led, Patient led, Consultant 
and Patient led). AG, NB and JF then trained a group of four Patient and Public Involvement 
(PPI) representatives, including the two PPI co-applicants (see below), in qualitative data 
analysis techniques.23 The PPI group developed the preliminary typology - identifying the 
terms ‘Patient identified’ (rather than ‘patient led’) and ‘Diabetologist facilitated’ (rather than 
‘Consultant led’) as more nuanced. For example, a consultation was defined as Patient 
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initiated and Diabetologist facilitated, when the doctor brought his agenda into play but he 
interweaved it into the patient’s agenda. These discussions were incorporated into a coding 
manual that defined each of the four categories, and which was used to further analyse the 
data and develop display matrices for each category (JF, LM).24 Both coders independently 
coded the dataset on the basis of those categories, and the small number of disagreements 
were resolved by discussion (e.g. revisiting the discussions with the PPI group). By applying 
this typology to the whole dataset, including the agenda forms, field notes, and interviews 
with patients and physicians, we sought to identify explanatory factors which mediated the 
production and utilisation of an agenda form. Completed matrices for the whole dataset were 
then discussed again with the PPI group, who confirmed the analyses.  
Patient and Public Involvement 
Patients identified the research question and were involved in the design and conduct of the 
research and dissemination of findings.16 With patient input, a project team was convened 
and a scoping exercise undertaken to assess what is known about the problem. Two patient 
representatives who have diabetes joined the research team as co-applicants on this 
proposal. Supported by a designated PPI Research Fellow (AG), these patient co-applicants 
were members of the project management team, who co-wrote the study documentation 
(including Patient Information Sheets and interview guides), assisted with training the Health 
Care Assistants (HCAs), and participated in the data analysis.25 A further group of 8 people 
with diabetes provided feedback on a prototype of the intervention. 
RESULTS 
Fifteen diabetologists working at the two centres were approached. Nine consented to 
participate and were formally inducted to the study in terms of the use of the agenda form, 
ethical practice and trial procedures. Patients were screened for eligibility (n=395). Of those 
who were eligible for the trial (n=380), 71 were recruited to the study, with 38 participants 
randomised to the intervention arm and 33 to the control arm (Table 1) Participants were 
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similar to eligible non-participants with respect to mean (SD) age at registration (56.5 (12.4) 
versus 51.3 (16.1)), type 1 (as opposed to type 2) diabetes status (66.2% vs 60.5%) and 
whether attending for a new appointment (4.2% vs 8.1%). With consent, 25 participants had 
their consultation with their diabetologist audio-recorded: 12 in the control arm and 13 in the 
intervention arm. Twelve of the latter had both their intervention session and consultation 
recorded. JF, an experienced qualitative researcher, then conducted semi-structured 
interviews with a purposive sample of 6 diabetologists, and 12 patients (6 in each trial arm) 
to contextualise our understanding. Patient interviews were conducted at their homes while 
all Diabetologists except one were interviewed in the clinic. Interviews lasted between 20 
and 60 minutes, and JF made field notes afterwards.  All participants and clinics were given 
pseudonyms in line with in line with the principles of the Declaration of Helsinki, 26 and the 
International Conference on Harmonisation-Good Clinical Practice (ICH GCP).27  
 
Table 1: Patient characteristics 
Characteristics  Control Intervention 
   
Full sample N =33 N= 38 
Centre (Moorland/Parkview), n 15/18 15/23 
Type of diabetes (Type 1/Type 2), n 24/9 23/15 
Age (years), mean 57.8 55.3 
Gender (male/female), n 18/15 19/19 
Ethnicity (White/Other/Missing), n 28/2/3 27/2/9 
Insulin (Yes/No/Missing), n 30/1/2 27/5/6 
Oral Medications (Yes/No/Missing), n 15/16/2 17/15/6 
First HbA1c (mmol/mol), mean 68.9 (N=30) 71.0 (N=29) 
   
Qualitative subsample   N=12 N= 13 
Centre (Moorland/Parkview), n 2/10 3/10 
Type of diabetes (Type 1/Type 2), n 6/6 8/5 
Age (years), mean 57.3 56.5 
Gender (male/female), n 6/6 7/6 
Ethnicity (White/Other/Missing), n 12/0/0 12/1/0 
Insulin (Yes/No/Missing), n 9/1/2 9/2/2 
Oral Medications (Yes/No/Missing), n 8/2/2 7/4/2 
First HbA1c (mmol/mol), mean 78.2 (N=12) 78.5 (N=12) 
Key: Insulin – Any Baseline with an injection. Oral – Any Baseline with a tablet medication. 
HbA1c – The first result only is taken. Missing – no Questionnaire returned.  
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Applying the PPI groups’ typology to the wider dataset enabled us to identify the key aspects 
that explained the production and utilisation of an agenda form: existing consultative style; 
orientation to the use of an agenda form; and, ultimately, the impact on the consultation.  
 
Existing consultative style  
In the control group we were able to identify each diabetologists’ usual style for eliciting 
information. For some this involved checking each medication and whether routine screening 
has been undertaken rather than asking patients about their concerns, while for others an 
open question was sufficient to set the tone of the consultation: 
So can I start by double checking some stuff with you, is that all right? And we’ll get 
on to what you want. (Mrs Brown, 49yrs/Dr Smith, Parkview, Control Group 
Consultation) 
 
How do you think things are? I mean, have you had any particular problems over the 
last month or two, or do you think it’s fairly stable and under reasonable control? (Mr 
Wilson, 79yrs/Dr Jones, Parkview, Control group Consultation) 
 
Unsurprisingly, this continuum is evident in the intervention group, with some diabetologists 
using their existing script prior to facilitating use of the agenda form, while others use the 
agenda form instead of their usual open questioning: 
 
So you very kindly agreed to take part in the study…Fantastic. And you’ve gone 
through that [Agenda] before, and we’re going to be using this as the basis for the 
consult today… (Miss Roberts, 52yrs/Dr Smith, Parkview Intervention group 
Consultation) 
 
We found no evidence of contamination between consultations in the intervention arm and 
the control arm (i.e. there were no examples of physicians changing what they did in usual 
practice as a result of participating in the trial). Rather, we identified that the diabetologists’ 
consultative style endured despite the use of an agenda form, with the agenda form acting 
as a magnifier of existing consultative style rather than as a mediator.  
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Patient experiences of participating in a diabetes consultation varied considerably. In some 
consultations we were able to discern much that is literally unsaid or shorthand, where both 
parties knew the broader context, due to their ongoing relationship: 
  
I’ve known her now for well over twenty years, and she has been nothing but nice, 
and stern if I’ve been naughty, you know, which is fair enough…And what it does, it 
makes me more enthusiastic to look after my diabetes. I go away feeling better and 
saying ‘Well, I must improve on that and must do this.’ Be nice if she could do it every 
fortnight that would be even better! (Mrs Johnson, 70yrs, Moorland, Control group 
Interview) 
 
In other consultations, agenda items were discussed at length, with the diabetologist using 
this as an opportunity to educate, inform or reassure their patients. Where people with 
diabetes and their diabetologist have a positive pre-existing relationship and share the same 
orientation to decision making (e.g. both have a preference for either the diabetologist or the 
patient leading the consultation) the agenda form augments existing relationships and 
mutual information sharing styles: 
 
She’s always interested in my view and respects my view, um, ‘cause we both know 
that I’ve been told that I can’t be cured and it’s just prophylactic care….And she’s 
said to me ‘If you think I’m trying to ask you to do things that is too much for you, you 
just say, and that.  Um, due to the fact that she’s also very, very interested in my 
illness. (Miss Clarke, 50yrs, Parkview Intervention group Interview) 
 
Where relationships are weaker and there is dissonance in information exchange (due to 
lack of an existing relationship or lack of agreed orientation), the agenda form amplifies 
existing tensions: 
I saw [diabetologist]. At the end of the consultation he said to me, erm, you have 10 
seconds is there anything else you would like to ask me which I thought was, you 
know, ha ha ha…couldn’t believe it, I was so gob smacked… I just walked out you 
know….Well he seemed very arrogant to me. (Mr Martin, 74yrs, Moorland, 
Intervention Session) 
 
 
 
Orientation to the use of the Intervention 
Consultative styles were not distributed equally across our typology. Most consultations had 
some examples of shared decision making (i.e. patient led or diabetologist facilitated), with 
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fewer examples of interactions that were either explicitly consultant led, or where the 
patients’ agenda remained unvoiced or was ignored.  
Despite participating in the study, two diabetologists did not embrace the philosophy of the 
project:  
I discuss the issues but I tend to find that I don’t get answers that I, that I 
want…Yeah, maybe the doctor’s got a different opinion about it, but I would like to 
see results and I don’t see the results… there’s always a different answer coming 
back to me from the um, the diabetic doctor... maybe I’ve got one way of thinking and 
he’s got a different way, you know. And when I said to him, you know, ‘What about 
an insulin pump, would that help?’ ‘Oh well, yeah, but you wouldn’t, it wouldn’t be any 
good for you’ and that’s it, you know, nothing’s tried. (Mr Wright, 52yrs, Parkview, 
Control group Interview) 
 
Two patients in the intervention arm were prevented from using the agenda as intended. Dr 
Smith wrongly believed that the intervention was making the clinic run over, and Miss Taylor 
was prevented from completing the intervention, to ensure that the clinic was not affected. 
Another patient, Mr. Davies, reported that he was told by Dr Green to ‘put the agenda form in 
his backpack’ because it was not needed. Although both instances may be due to 
misperceptions about the impact of the study on clinic waiting times,17 evidence from the 
consultations suggests that both of these diabetologists typically favour a more Consultant-
led style of consultation: 
 
I don’t think the agenda improved it at all, it may have been slightly useful for her but 
from my perspective we discussed two things that weren’t relevant to diabetes. So I 
was doing a general practitioner role and we over ran by about 10 minutes as a result 
so I have considered that a negative experience on my behalf, but she may have 
liked it. (Dr Smith, Moorland, Message left for researchers on audio recorder).  
 
Some patients did not produce their own agenda (e.g. Mr White), and took blank forms to 
consultations, suggesting to the HCA that they did not have any concerns or that they were 
satisfied with how the diabetologist conducted the consultation. 
 
In contrast, there were more diabetologists with a more facilitative predisposition, who 
embraced the ethos of the agenda form, and permitted patients to set the agenda for the 
consultation, even if this led to patients discussing unrelated issues: 
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I seem to remember one of the questions that they asked … it was really off the wall, 
as in it was really not really at all relevant in terms of their care ... it introduced new 
topics that I wouldn’t have brought up myself and they might not have otherwise 
done…And they say this all the time ‘Is this something I can discuss here or is this 
something I should discuss with the GP?”  (Dr Williams, Moorland, Interview) 
 
Well, I thought it was, one of the reasons I was interested in the study was ‘cause I 
am concerned, so - my background to this is I watch my friends who’ve all become 
GPs, get trained in consultation skills and how to set up consultations …And since 
some of the principles of the study involved sort of setting up a patient agenda and 
maybe an alternative way of tackling a consultation that improved patients wellbeing, 
might potentially improve patient engagement with that process … (Dr Thomas, 
Parkview, Interview) 
 
Patients who engaged with the intervention highlighted pre-suggested issues and/or used 
the form to write their own list of questions or concerns - with only some highlighting the 
three most important issues as instructed. The most common agenda item was medication 
and insulin management specifically. 
 
I think [the agenda form] was good idea...  ‘cause I must admit I go down to the 
doctors’ and you go on to one thing and then suddenly summat’ll be said and then 
they go off in a direction and then you’ve got to try and get back on to what you want 
to talk about….we just went through the agenda, basically, you know, we’d talk about 
this, what are you doing, where’s your weight, you know, what’s your sugar levels 
and everything else… (Mr Hughes, 55yrs, Parkview, Intervention group Interview) 
 
Impact on the consultation  
 
Having identified the significance of existing consultative styles and orientations, we then 
explored how they related to the PPI identified typology and the use of an agenda form: 
 
Patients were ignored when, despite completing an agenda form, the diabetologist stuck to 
their regular script and conducted business as usual. These diabetologists often declined to 
have their consultations recorded, despite the patient consenting, and information was thus 
gathered from observations and conversations in the clinic, or by interview with the patient at 
home. For example, this patient had three questions on her agenda form but perceived that 
she has still not been able to discuss them (Figure1):  
 
Well, what I mean is probably I don’t talk. I can’t talk about the impact on my life, like 
you’ve asked me today [in the qualitative interview] mostly it’s all internalised in my 
head, my experiences of diabetes. (Mrs Edwards, 76yrs, Moorland, Intervention 
group Interview) 
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Consultations were Consultant facilitated when the diabetologist stuck to their pre-existing 
script or maintained business as usual despite the participant writing a list of concerns. In 
this example the diabetologist focused on the patients’ perceived lack of understanding 
rather than their agenda: 
 
D: Since the exenatide hasn’t worked I don’t have another treatment that will help 
your diabetes and also cause weight loss or isn’t any other treatment we have. So 
insulin is what we have to go with, okay and your blood sugar levels have been very 
high, and I can see from that blood test they have been worryingly high so I would 
say to you that we do need to increase the insulin dose and in fact get your blood 
sugars down. 
P: By how much, you know? 
D: I don’t know, so be clear just try that, bear with me sir, please bear with me. I don’t 
know now how much insulin you will need, so some people need… 
P: How is that you can be so certain that exenatide is not doing me any good… yet 
you failed to tell me what dose I should be taking of insulin. 
D: I think you should just listen and I will answer that question for you… With insulin 
different people have hugely different requirements so some people take 20 units a 
day, some people might take several hundred units in a day, okay. So if I look at you 
and you say to me, how much insulin do I need? The answer is I do not know how 
much insulin but we have a way of finding out, so the answer is we increase the 
dose, until your blood sugars come down, so otherwise this case would increase, an 
increase until we get the dose right, okay.  
P: But by how much? 
D: That is something I can’t tell you, I am just explaining. 
(Mr. Martin, 74yrs/Dr Smith, Moorland, Intervention group Consultation) 
 
Mr. Martin and Dr Smith had an established relationship, and we found no evidence that 
having an enduring relationship in itself was a guarantee of agenda facilitation. Nor did we 
find evidence that the age of the patient determined either their desire or experience of 
shared decision making, although we acknowledge that due to recruitment challenges our 
sample was small.  
 
Consultations were Consultant facilitated and patient initiated when pre-existing relationships 
were positive and/or the ethos of shared decision making was embraced. In this example the 
participant had recently been diagnosed with dementia and attended the clinic with his wife 
who was his carer. They identified 12 concerns, and the diabetologist focused upon his 
primary concern, which was tiredness:  
 
D: Good to have [your] concerns. Right, OK. Right, nice to see you again. 
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P: Yes. 
D: It’s been a little while hasn’t it… Since I saw you last time. … Yeah, how are you 
anyway, bring me up to date 
P: Going down really, aren’t I?... I was getting so tired, very tired, you know, got no 
energy at all. I don’t know that’s the diabetes or the, um… 
D: So that’s still the main concern, really, from your end of the line, this fatigue, we 
just haven’t really got on top of that…. 
P: … Oh yes, just been diagnosed with dementia as well, the start of dementia… 
D: You have? 
P: Vascular dementia… 
D: How did that come about? 
P: Um, it’s just my GP, we were talking to the GP and I was saying I was beginning to 
forget a lot of things and she did a few tests and um, said ‘Yeah, it looks as though 
you are’ and she sent me off to see a specialist in [place]… 
D: Have you stopped any treatment that you were on, or are you basically finding you 
still need all the same? 
P: I still need all the same stuff… 
D: Right. Um, there’s a few things I suspect we need to chat about today. Were there 
any other specific concerns that you had at this point? 
P: Not really, no...  
D: That’s the general issue. (Mr Lewis, 74yrs/Dr Smith, Parkview, Intervention group 
Consultation) 
 
Few consultations were Patient Identified. This tended to occur when patients had greater 
material advantage, e.g. they were a health professional with a similar repertoire of 
knowledge, long standing patients who were competent at self-management, or a new 
patient already versed in shared decision making. In this example a new patient, who had 
recently returned to the UK from living overseas, was able to articulate a range of concerns 
for the diabetologist to address:  
D: Can I ask you, you’ve gone through an agenda before you came in this morning, 
what were the areas of concern that, um, you wanted to discuss today? 
P: Well, I think now that I’ve basically on the insulin and getting my diabetes 
organised is the neuropathy that’s of most concern right now.  
D: So there’s … 
P: It’s affecting my lifestyle to such an extent, I’m not sleeping. Because I walk every 
day, I mean, you have to walk, but it’s just um, I mean, I like to do all the travelling 
and walking and I’m concerned about it, how it’s going to affect my lifestyle.  
D : How is it affecting you currently? So what symptoms does your neuropathy give 
you currently? 
P : Er, a lot of pain, aching, deep ache…. 
D: OK. Apart from pain, does it affect you any other way? Is pain the main feature at 
the moment, is it that when you’re walking you’re unsteady at all, or…? 
P: Yeah, my balance has been affected, yes.  
D: OK. So there’s your neuropathy, concern number one. Were you saying that your 
diabetes, just levelling out your glucose levels, your glucose values, was also a 
concern to you, getting those optimised, is that part of your…? 
P: Oh obviously, it’s going to, yeah, that’s a major concern, yeah, just getting those 
level, get it right, diet organised, those levelled out and just the feeling of being, I feel 
like I’ve got the ‘flu all the time, just tired.  
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D: You’re tired, OK.  
P: Just tired all the time. So, I mean, I don’t know whether there’s any health things, I 
haven’t had a complete health checkup for years, so, I mean, it’s just really difficult.  
D: OK, but those are the … are there any other areas you want to bring up today, or 
are those the three? 
P: No, those are the three, yeah. (Mrs Harris, 65 yrs/Dr Thomas, Parkview, 
Intervention group Consultation) 
 
In the wider transcript of the consultation Mrs Harris suggests that her motivation for asking 
questions was the differing experiences of diabetes provision that she experienced in both 
North America and Australia, and her recent diagnosis of neuropathy, which she interpreted 
as a sign of deterioration.  
 
DISCUSSION 
The principal finding is that where patients and diabetologists have a shared preference for a 
consultant-led or patient-led consultation the PACE-D augments effective communication 
and shared decision making. However, where preferences diverge PACE-D does not 
improve the potential for shared decision making (i.e. concerns could remain unvoiced or 
ignored). The trial design allowed us to compare individual consultative styles across arms, 
outpatient settings and between cases. The majority of patients who completed the PACE-D 
found the intervention acceptable, and suggested that it helped them to think about issues 
related to their care.17 Our qualitative findings provide insights into how an agenda form may 
(or may not) function in medical consultations where patient concerns are often 
discounted.28,29  
 
Our findings support those of previous research that utilised a single exposure intervention 
for prioritising diabetes-related treatment goals:30 PACE-D did not universally improve 
patient empowerment, but acted as a magnifier for pre-existing consultative styles and 
orientations. Our findings are similar to those of Rhodes et al (2006) who identified that at 
worst, patients can experience ‘industrialisation’ of diabetes care whereby their concerns are 
diminished by the demands of the clinic, while at best the clinician can use the introduction 
of an intervention as an opportunity to practise patient-centred care. 31 Key challenges that 
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we identified include: lack of resources in the outpatient setting (including lack of time and 
space for an intervention) and lack of buy-in from clinicians despite consenting to participate. 
Any future research would need to give these contextual factors greater consideration in the 
designing and planning stages.  
 
A limitation of this study is that although we planned recruitment of 120 participants, only 71 
participants were randomised during the 7-month recruitment period, and only half agreed to 
participate in this qualitative study. We have previously identified that a randomised 
controlled trial of the preconsultation web-based intervention as set out in our current 
protocol is not feasible without significant modification to improve recruitment and follow-up 
of participants.17 However, triangulating data from interventions sessions, consultations, 
agenda forms and interviews allowed us to identify the extent to which individual patient 
concerns were addressed in a given consultation.23 As a recent systematic review of 
interventions to improve health outcomes arising from patient-clinician encounters failed to 
include trials that sought to explicitly empower patients,31 our findings suggest that more now 
needs to be done to explore which interventions patients consider to be most effective at 
addressing their concerns.  
 
A strength of this study is the participation of patient representatives at all stages of the 
study enabled them to make a valuable contribution to our understanding of intervention 
development and implementation. We concluded that it would not be appropriate to run a 
definitive randomised controlled trial without amending our intervention in order to optimise 
the elicitation and utilisation of the patients’ agenda.  
 
Conclusion: a simple web-based intervention can facilitate the articulation of patients’ 
unvoiced agenda for a consultation with their diabetologist, but only when pre-existing 
consultation styles and orientations already favour shared-decision making. More needs to 
16 
 
be done to translate patient empowerment in the consultation setting into genuine self-
efficacy. 
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Figure 1: Agenda Form for Mrs Edwards 
 
 
 
 
 
 
 
